» Articles » PMID: 30126950

Comparison Between High-Sensitivity Cardiac Troponin T and Cardiac Troponin I in a Large General Population Cohort

Abstract

Background: Few data compare cardiac troponin T (cTnT) and cardiac troponin I (cTnI) in a general population. We sought to evaluate the distribution and association between cTnT, cTnI, and cardiovascular risk factors in a large general population cohort.

Methods: High-sensitivity cTnT and cTnI were measured in serum from 19501 individuals in the Generation Scotland Scottish Family Health Study. Associations with cardiovascular risk factors were compared using age- and sex-adjusted regression. Observed age- and sex-stratified 99th centiles were compared with 99th centiles for cTnT (men, 15.5 ng/L; women, 9.0 ng/L) and cTnI (men, 34.2 ng/L; women, 15.6 ng/L) used in clinical practice.

Results: cTnT and cTnI concentrations were detectable in 53.3% and 74.8% of participants, respectively, and were modestly correlated in unadjusted analyses ( = 21.3%) and only weakly correlated after adjusting for age and sex ( = 9.5%). Cardiovascular risk factors were associated with both troponins, but in age- and sex-adjusted analyses, cTnI was more strongly associated with age, male sex, body mass index, and systolic blood pressure ( < 0.0001 for all vs cTnT). cTnT was more strongly associated with diabetes ( < 0.0001 vs cTnI). The observed 99th centiles were broadly consistent with recommended 99th centiles in younger men and women. After the age of 60 years, observed 99th centiles increased substantially for cTnT, and beyond 70 years of age, the 99th centiles approximately doubled for both troponins.

Conclusions: In the general population, cTnT and cTnI concentrations are weakly correlated and are differentially associated with cardiovascular risk factors. The 99th centiles currently in use are broadly appropriate for men and women up to but not beyond the age of 60 years.

Citing Articles

Predictive value and optimal cut-off level of high-sensitivity troponin T in patients with acute pulmonary embolism.

Kim M, Seo C, Kim Y, Kim H, Kim H, Cho Y Korean J Intern Med. 2025; 40(1):65-77.

PMID: 39778527 PMC: 11725470. DOI: 10.3904/kjim.2024.131.


Prediction Models for Elevated Cardiac Biomarkers from Previous Risk Factors and During the COVID-19 Pandemic in Residents of Trujillo City, Peru.

Caballero-Vidal J, Diaz-Ortega J, Yupari-Azabache I, Castro-Caracholi L, Alva Sevilla J Diagnostics (Basel). 2024; 14(22).

PMID: 39594168 PMC: 11592570. DOI: 10.3390/diagnostics14222503.


Management of Acute Coronary Syndrome in Elderly Patients: A Narrative Review through Decisional Crossroads.

Verardi R, Iannopollo G, Casolari G, Nobile G, Capecchi A, Bruno M J Clin Med. 2024; 13(20).

PMID: 39457985 PMC: 11508245. DOI: 10.3390/jcm13206034.


Close Cardiovascular Monitoring during the Early Stages of Treatment for Patients Receiving Immune Checkpoint Inhibitors.

Delombaerde D, Vulsteke C, Van de Veire N, Vervloet D, Moerman V, Van Calster L Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065813 PMC: 11279915. DOI: 10.3390/ph17070965.


The impact of obesity, age, and gender on plasmatic levels of selected glycoprotein biomarkers and miRNA-499 in OSA patients.

Kostlivy T, Pesta M, Windrichova J, Skopek P, Klail P, Skalova A J Appl Biomed. 2024; 22(2):81-88.

PMID: 38912863 DOI: 10.32725/jab.2024.011.


References
1.
Shah A, Griffiths M, Lee K, McAllister D, Hunter A, Ferry A . High sensitivity cardiac troponin and the under-diagnosis of myocardial infarction in women: prospective cohort study. BMJ. 2015; 350:g7873. PMC: 4301191. DOI: 10.1136/bmj.g7873. View

2.
Gore M, Seliger S, deFilippi C, Nambi V, Christenson R, Hashim I . Age- and sex-dependent upper reference limits for the high-sensitivity cardiac troponin T assay. J Am Coll Cardiol. 2014; 63(14):1441-8. PMC: 3984900. DOI: 10.1016/j.jacc.2013.12.032. View

3.
Lyngbakken M, Brox Skranes J, de Lemos J, Nygard S, Dalen H, Hveem K . Impact of Smoking on Circulating Cardiac Troponin I Concentrations and Cardiovascular Events in the General Population: The HUNT Study (Nord-Trøndelag Health Study). Circulation. 2016; 134(24):1962-1972. DOI: 10.1161/CIRCULATIONAHA.116.023726. View

4.
Klinkenberg L, Luyten P, van der Linden N, Urgel K, Snijders D, Knackstedt C . Cardiac Troponin T and I Release After a 30-km Run. Am J Cardiol. 2016; 118(2):281-7. DOI: 10.1016/j.amjcard.2016.04.030. View

5.
Wildi K, Gimenez M, Twerenbold R, Reichlin T, Jaeger C, Heinzelmann A . Misdiagnosis of Myocardial Infarction Related to Limitations of the Current Regulatory Approach to Define Clinical Decision Values for Cardiac Troponin. Circulation. 2015; 131(23):2032-40. PMC: 4456170. DOI: 10.1161/CIRCULATIONAHA.114.014129. View